These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6147810)

  • 1. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
    Andersson S; Nemeth A; Ohisalo J; Strandvik B
    Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical observations on so-called hereditary tyrosinemia.
    Gaull GE; Rassin DK; Solomon GE; Harris RC; Sturman JA
    Pediatr Res; 1970 Jul; 4(4):337-44. PubMed ID: 4393588
    [No Abstract]   [Full Text] [Related]  

  • 3. Oculocutaneous tyrosinosis. Report of two cases in the same family.
    Garibaldi LR; Siliato F; de Martini I; Scarsi MR; Romano C
    Helv Paediatr Acta; 1977 Jul; 32(2):173-80. PubMed ID: 33934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tyrosinemia II].
    Kalimo K; Ivaska K; Koistinen T; Havu VK
    Duodecim; 1985; 101(16):1585-9. PubMed ID: 2865123
    [No Abstract]   [Full Text] [Related]  

  • 5. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B; Lindstedt S; Steen G
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The metabolic basis of the hyperphenylalaninemias and tyrosinemia].
    Shintaku H
    Nihon Rinsho; 1992 Jul; 50(7):1542-7. PubMed ID: 1357201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
    Sassa S; Fujita H; Kappas A
    Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosinemia: the Quebec experience.
    Paradis K
    Clin Invest Med; 1996 Oct; 19(5):311-6. PubMed ID: 8889268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.
    Shoemaker LR; Strife CF; Balistreri WF; Ryckman FC
    Pediatrics; 1992 Feb; 89(2):251-5. PubMed ID: 1734392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of Richner-Hanhart syndrome (tyrosinosis with ocular, cutaneous and mental manifestations].
    Goddé-Jolly D; Larregue M; Roussat B; Van Effenterre G
    J Fr Ophtalmol; 1979 Jan; 2(1):23-8. PubMed ID: 34642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
    Goldsmith LA; Thorpe J; Roe CR
    J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
    N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine aminotransferase activity in human fetal liver.
    Andersson SM; Räihä NC; Ohisalo JJ
    J Dev Physiol; 1980; 2(1-2):17-27. PubMed ID: 6108340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic studies on two patients with nonhepatic tyrosinemia using deuterated tyrosine loads.
    Faull KF; Gan I; Halpern B; Hammond J; Im S; Cotton RG; Danks DM; Freeman R
    Pediatr Res; 1977 May; 11(5):631-7. PubMed ID: 870870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW; Dakshinamurti K; Allan L; Haworth JC
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia].
    Bélanger L; Bélanger M; Prive L; Larochelle J; Tremblay M; Aubin G
    Pathol Biol (Paris); 1973 May; 21(5):449-55. PubMed ID: 4125220
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hereditary tyrosinemia type II].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):134-6. PubMed ID: 9590007
    [No Abstract]   [Full Text] [Related]  

  • 19. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.